None of the factors, including age (coefficient: 0.10, P = .29), BMI (coefficient: −0.45, P = .71), MTX (coefficient: −0.07, P = .90), AST (coefficient: −0.05, P = .55), ALT (coefficient: −0.03, P = .59), TG (coefficient: −0.03, P = .22), total cholesterol (coefficient: 0.11, P = .43), DM2 (coefficient: 0.00, P = .23), or HTN (coefficient: −0.05, P = .41), had a significant effect on the prevalence of NAFLD/NASH in RA patients (Fig. 4). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.